Harzand, Arash
Alrohaibani, Alaaeddin
Idris, Muhammed Y.
Spence, Hayden
Parrish, Cate G.
Rout, Pratik K.
Nazar, Rene
Davis-Watts, Michelle L.
Wright, Phyllis P.
Vakili, Alexander A.
Abdelhamid, Smah
Vathsangam, Harshvardhan
Adesanya, Adelanwa
Park, Linda G.
Whooley, Mary A.
Wenger, Nanette K.
Zafari, A. Maziar
Shah, Amit J.
Funding for this research was provided by:
U.S. Department of Veterans Affairs
Article History
Received: 25 January 2023
Accepted: 23 August 2023
First Online: 12 September 2023
Declarations
:
: All the patients provided informed consent before enrollment. The Institutional Review Board at Emory University and the Research & Development Committee at the Department of Veterans Affairs approved the study protocol. The study was conducted in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.
: Not applicable.
: Dr. Harzand reports consulting fees and a minority ownership interest in Movn Health. The remaining authors have no actual or potential conflicts of interest to declare. Dr. Vathsangam is an employee and minority shareholder in Movn Health. Mr. Adesanya is an employee and minority shareholder in Movn Health.